Search

Search Results

• PO:32:182 | Disease characteristics of anti-centromere positive systemic sclerosis patients and risk factors for organ involvement: data from the EUSTAR cohort Corrado Campochiaro¹, Jelena Colic², Del Papa Nicoletta³, Oliver Distler⁴, Serena Guiducci⁵, Florenzo Iannone⁶, David Launay⁷, Yair Levy⁸, Britta Maurer⁹, Arsene Mekinian¹⁰, Predrag Ostojic², Gabriela Riemekasten¹¹, Petros Sfikakis¹², Bojana Stamenkov¹³, Ulrich Walker¹⁴, Marie Elise Truchetet¹⁵, Madelon Vonk¹⁶, Francesco Del Galdo¹⁷, Giacomo De Luca¹, Lorenzo Dagna¹, Marco Matucci Cerinic¹, Yannick Allanore¹⁸ | ¹IRCCS San Raffaele Hospital; Vita Salute San Raffaele University Milan, Italy; ²University of Belgrade Belgrade, Serbia; ³UOC Reumatologia Clinica, ASST G. Pini CTO Milan, Italy; ⁴University Hospital Zurich Zurich, Switzerland; ⁵Department of Rheumatology, University of Florence Florence, Italy; ⁶Rheumatology Unit Bari, Italy; ⁷CHU Lille Lille, France; ⁸Department of Medicine Kfar Saba, Israel; ⁹Department for BioMedical Research, University of Bern Bern, Switzerland; ¹⁰Service de medecine interne Paris, France; ¹¹Department of Rheumatology University of Lubeck Lubeck Germany; ¹²National and Kapodistrian University of Athens Athens, Greece; ¹³University School of Medicine, Nis Nis, Serbia; ¹⁴University Hospital Basel, Basel Basel, Switzerland; ¹⁵Bordeaux Hospital and University Bordeaux, France; ¹⁶Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; ¹⁷Leeds Institute of Rheumatic and Muskuloskeletal Medicine Leeds, United Kingdom; ¹⁸Cochin Hospital Paris, France

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2372

  13

• PO:32:176 | Outcomes of upfront combination vs monotherapy with rituximab or mycophenolate mofetil for systemic sclerosis interstitial lung disease: results from a European Scleroderma Trials and Research cohort study Devis Benfaremo¹, Corrado Campochiaro², Gábor Kumánovics³, Christina Bergmann⁴, Elisabetta Zanatta⁵, David Launay⁶, Serena Guiducci⁷, Mickael Martin⁸, Carolina De Souza Müller⁹, Carlomaurizio Montecucco¹⁰, Luc Mouthon¹¹, Gabriella Szucs¹², Kastriot Kastrati¹³, Marie-Elise Truchetet¹⁴, Madelon Vonk¹⁵, Francesco Del Galdo¹⁶, Marco Matucci-Cerinic², Gianluca Moroncini¹, Yannick Allanore¹⁷. | ¹Department of Clinical and Molecular Sciences, Marche Polytechnic University, Marche University Hospital, Ancona, Italy; ²Vita-Salute San Raffaele University, San Raffaele Hospital, Milano, Italy; ³University of Pécs, Department Of Rheumatology And Immunology, Pécs, Hungary; ⁴University Hospital Erlangen, Department Internal Medicine 3, Erlangen, Germany; ⁵Padova University Hospital, Rheumatology Unit, Padova, Italy; ⁶Univ. Lille, Inserm, CHU Lille, Department of Internal Medicine and Clinical Immunology, Lille, France; ⁷University of Florence, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy; ⁸Poitiers University Hospital, Department of Internal Medicine Poitiers France; ⁹Hospital de Clinicas da Universidade Federal do Parana Curitiba Brazil; ¹⁰Università di Pavia e IRCCS Fondazione Policlinico S. Matteo, Pavia, Italy; ¹¹Hôpital Cochin, Department of Internal Medicine, Paris, France; ¹²University of Debrecen, Faculty of Medicine, Department of Rheumatology, Debrecen, Hungary; ¹³Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria; ¹⁴CHU de Bordeaux, Rheumatology department, Bordeaux, France; ¹⁵Radboudumc, Department of Rheumatology Nijmegen The Netherlands; ¹⁶Leeds Raynauds and Scleroderma Program, NIHR Biomedical Research Centre, Leeds, United Kingdom; ¹⁷Université Paris Cité, Cochin Hospital, Rheumatology Department, Paris, France.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2077

  143